Ponholzer Florian, Ng Caecilia, Maier Herbert, Dejaco Hannes, Schlager Andreas, Lucciarini Paolo, Öfner Dietmar, Augustin Florian
Center of Operative Medicine, Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Department of Anaesthesiology and Critical Care, Medical University of Innsbruck, 6020 Innsbruck, Austria.
J Clin Med. 2021 Jan 19;10(2):372. doi: 10.3390/jcm10020372.
Postoperative pain after video-assisted thoracoscopic surgery (VATS) affects patients' recovery, postoperative complications, and length of stay (LOS). Despite its relevance, there are no guidelines on optimal perioperative pain management. This study aims to analyse the effects of an additional intercostal catheter (ICC) in comparison to a single shot intraoperative intercostal nerve block (SSINB).
All patients receiving an anatomic VATS resection between June 2019 and May 2020 were analysed retrospectively. The ICC cohort included 51 patients, the SSINB cohort included 44 patients.
There was no difference in age, gender, comorbidities, or duration of surgery between cohorts. Pain scores on the first postoperative day, after chest drain removal, and highest pain score measured did not differ between groups. The overall amount of opioids (morphine equivalent: 3.034 mg vs. 7.727 mg; = 0.002) as well as the duration of opioid usage (0.59 days vs. 1.25 days; = 0.005) was significantly less in the ICC cohort. There was no difference in chest drain duration, postoperative complications, and postoperative LOS.
Pain management with ICC reduces the amount of opioids and number of days with opioids patients require to achieve sufficient analgesia. In conclusion, ICC is an effective regional anaesthesia tool in postoperative pain management in minimally invasive thoracic surgery.
电视辅助胸腔镜手术(VATS)后的术后疼痛会影响患者的恢复、术后并发症及住院时间(LOS)。尽管其具有相关性,但目前尚无关于围手术期最佳疼痛管理的指南。本研究旨在分析与单次术中肋间神经阻滞(SSINB)相比,额外放置肋间导管(ICC)的效果。
对2019年6月至2020年5月期间接受解剖性VATS切除术的所有患者进行回顾性分析。ICC队列包括51例患者,SSINB队列包括44例患者。
各队列之间在年龄、性别、合并症或手术时长方面无差异。术后第一天、拔除胸腔引流管后及测量的最高疼痛评分在两组之间无差异。ICC队列中阿片类药物的总量(吗啡当量:3.034 mg对7.727 mg;P = 0.002)以及阿片类药物使用时长(0.59天对1.25天;P = 0.005)显著更低。胸腔引流管留置时间、术后并发症及术后住院时间无差异。
使用ICC进行疼痛管理可减少患者实现充分镇痛所需的阿片类药物用量及使用天数。总之,ICC是微创胸外科术后疼痛管理中一种有效的区域麻醉工具。